ELOX

10.6900.38%
DB

David Bedwell

Member of Scientific Advisory Board

Dr. David Bedwell, Ph.D., has been Member of Scientific Advisory Board at Eloxx Pharmaceuticals, Inc. since May 10, 2018. Dr. Bedwell is a Professor and Chairman of James C. and Elizabeth T. Lee Endowed Chair of Biochemistry, Department of Biochemistry & Molecular Genetics, University of Alabama at Birmingham School of Medicine. Dr. Bedwell also currently serves as Associate Director of the Cystic Fibrosis Research Center and Co-Director of the UAB Structural Biology Program. He was elected Fellow of the American Academy of Microbiology in 2011. Dr. Bedwell’s lab studies the mechanistic details of translation termination and Nonsense-Mediated mRNA Decay (NMD).

Positions